Kanawha Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.62M | Sell |
43,234
-2,118
| -5% | -$123K | 0.18% | 83 |
|
|
2025
Q4 | $2.45M | Buy |
45,352
+10,233
| +29% | +$492K | 0.17% | 85 |
|
|
2025
Q3 | $1.58M | Sell |
35,119
-2,632
| -7% | -$123K | 0.11% | 99 |
|
|
2025
Q2 | $1.75M | Buy |
37,751
+557
| +1% | +$27.3K | 0.13% | 96 |
|
|
2025
Q1 | $2.27M | Buy |
37,194
+977
| +3% | +$56.9K | 0.18% | 89 |
|
|
2024
Q4 | $2.05M | Sell |
36,217
-544
| -1% | -$30.4K | 0.16% | 87 |
|
|
2024
Q3 | $1.9M | Sell |
36,761
-2,247
| -6% | -$105K | 0.14% | 101 |
|
|
2024
Q2 | $1.62M | Sell |
39,008
-11,745
| -23% | -$526K | 0.13% | 103 |
|
|
2024
Q1 | $2.75M | Sell |
50,753
-10,361
| -17% | -$528K | 0.22% | 83 |
|
|
2023
Q4 | $3.14M | Sell |
61,114
-10,457
| -15% | -$549K | 0.29% | 73 |
|
|
2023
Q3 | $4.15M | Sell |
71,571
-1,251
| -2% | -$76.7K | 0.4% | 66 |
|
|
2023
Q2 | $4.66M | Buy |
72,822
+1,280
| +2% | +$85.8K | 0.43% | 62 |
|
|
2023
Q1 | $4.96M | Buy |
71,542
+126
| +0.2% | +$8.89K | 0.48% | 59 |
|
|
2022
Q4 | $5.14M | Buy |
71,416
+1,722
| +2% | +$130K | 0.5% | 59 |
|
|
2022
Q3 | $4.96M | Sell |
69,694
-4,424
| -6% | -$321K | 0.54% | 58 |
|
|
2022
Q2 | $5.71M | Sell |
74,118
-336
| -0.5% | -$25.6K | 0.58% | 56 |
|
|
2022
Q1 | $5.44M | Sell |
74,454
-3,281
| -4% | -$220K | 0.48% | 61 |
|
|
2021
Q4 | $4.85M | Buy |
77,735
+264
| +0.3% | +$15.5K | 0.41% | 63 |
|
|
2021
Q3 | $4.58M | Buy |
77,471
+66
| +0.1% | +$4.35K | 0.42% | 65 |
|
|
2021
Q2 | $5.17M | Sell |
77,405
-1,491
| -2% | -$97.2K | 0.47% | 63 |
|
|
2021
Q1 | $4.98M | Buy |
78,896
+843
| +1% | +$52.5K | 0.48% | 60 |
|
|
2020
Q4 | $4.84M | Buy |
78,053
+5,162
| +7% | +$317K | 0.5% | 58 |
|
|
2020
Q3 | $4.39M | Sell |
72,891
-446
| -0.6% | -$26.8K | 0.51% | 57 |
|
|
2020
Q2 | $4.31M | Buy |
73,337
+94
| +0.1% | +$5.62K | 0.53% | 57 |
|
|
2020
Q1 | $4.08M | Sell |
73,243
-311
| -0.4% | -$19K | 0.6% | 55 |
|
|
2019
Q4 | $4.72M | Buy |
73,554
+5,295
| +8% | +$303K | 0.55% | 57 |
|
|
2019
Q3 | $3.46M | Sell |
68,259
-1,680
| -2% | -$79K | 0.45% | 61 |
|
|
2019
Q2 | $3.17M | Buy |
69,939
+1,634
| +2% | +$76.1K | 0.42% | 65 |
|
|
2019
Q1 | $3.26M | Sell |
68,305
-21
| -0% | -$1.05K | 0.46% | 63 |
|
|
2018
Q4 | $3.55M | Sell |
68,326
-41
| -0.1% | -$2.2K | 0.56% | 57 |
|
|
2018
Q3 | $4.24M | Buy |
68,367
+792
| +1% | +$47K | 0.59% | 57 |
|
|
2018
Q2 | $3.74M | Sell |
67,575
-621
| -0.9% | -$33.5K | 0.56% | 59 |
|
|
2018
Q1 | $4.31M | Sell |
68,196
-972
| -1% | -$62.5K | 0.65% | 57 |
|
|
2017
Q4 | $4.24M | Sell |
69,168
-372
| -0.5% | -$23.3K | 0.62% | 58 |
|
|
2017
Q3 | $4.43M | Sell |
69,540
-692
| -1% | -$40.4K | 0.68% | 55 |
|
|
2017
Q2 | $3.91M | Buy |
70,232
+154
| +0.2% | +$8.38K | 0.61% | 59 |
|
|
2017
Q1 | $3.81M | Buy |
70,078
+2,403
| +4% | +$132K | 0.61% | 59 |
|
|
2016
Q4 | $3.96M | Buy |
67,675
+4,876
| +8% | +$267K | 0.66% | 55 |
|
|
2016
Q3 | $3.39M | Buy |
62,799
+4,877
| +8% | +$313K | 0.57% | 60 |
|
|
2016
Q2 | $4.26M | Sell |
57,922
-48
| -0.1% | -$3.39K | 0.71% | 56 |
|
|
2016
Q1 | $3.7M | Buy |
57,970
+502
| +0.9% | +$31.7K | 0.64% | 56 |
|
|
2015
Q4 | $3.95M | Buy |
57,468
+1,156
| +2% | +$76.4K | 0.71% | 55 |
|
|
2015
Q3 | $3.33M | Buy |
56,312
+52
| +0.1% | +$3.3K | 0.64% | 55 |
|
|
2015
Q2 | $3.74M | Sell |
56,260
-578
| -1% | -$38.1K | 0.66% | 55 |
|
|
2015
Q1 | $3.67M | Sell |
56,838
-2,150
| -4% | -$135K | 0.64% | 57 |
|
|
2014
Q4 | $3.48M | Sell |
58,988
-1,298
| -2% | -$73.2K | 0.61% | 58 |
|
|
2014
Q3 | $3.08M | Buy |
60,286
+906
| +2% | +$45.3K | 0.56% | 60 |
|
|
2014
Q2 | $2.88M | Buy |
59,380
+332
| +0.6% | +$16.4K | 0.53% | 65 |
|
|
2014
Q1 | $3.07M | Sell |
59,048
-1,397
| -2% | -$74.3K | 0.58% | 60 |
|
|
2013
Q4 | $3.21M | Sell |
60,445
-498
| -0.8% | -$25.4K | 0.61% | 59 |
|
|
2013
Q3 | $2.82M | Buy |
60,943
+81
| +0.1% | +$3.56K | 0.58% | 61 |
|
|
2013
Q2 | $2.72M | Buy |
+60,862
| New | +$2.64M | 0.6% | 61 |
|
Other funds holding BMY
VCM
VPM
Kanawha Capital Management's BMY Position: Q1 2026 in Review
Kanawha Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 4.7% in Q1 2026, selling an estimated $123K and leaving 43,234 shares worth $2.62M. The position accounts for 0.18% of the portfolio, ranked #83.
Kanawha Capital Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.71M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Kanawha Capital Management held 43,234 shares of Bristol-Myers Squibb worth $2.62M as of Q1 2026.
- Kanawha Capital Management sold 2,118 Bristol-Myers Squibb shares in Q1 2026, an estimated $123K.
- Bristol-Myers Squibb made up 0.18% of Kanawha Capital Management's portfolio in Q1 2026, its #83 holding.
- Kanawha Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Kanawha Capital Management's Bristol-Myers Squibb position peaked at $5.71M in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Kanawha Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.